Hubei Honch Pharmaceutical Co., Ltd

Located in Hubei province, China, Hubei Honch Pharmaceutical Co., Ltd currently lists five active products in its catalogue. The product set includes four vinblastine‑type alkaloids - Vinorelbine tartrate, Vinorelbine base, Vinblastine sulfate, and Paclitaxel - as well as the taxane Docetaxel. All items fall under the supplier’s stated top categories of Pharmaceutical Raw Material & Intermediates, Industrial Chemicals, and Laboratory Chemicals, and are presented without additional branding or client claims. The catalogue does not provide HS‑code designations, so the listing is limited to the product names and their chemical class. The supplier is classified as an imported tier with a harbor trust rating, indicating a moderate level of verification within the platform’s trust framework.

The five listed compounds are widely used as cytotoxic agents in oncology research and formulation. Vinorelbine and Vinblastine derivatives are alkaloid‑based mitotic inhibitors, while Docetaxel and Paclitaxel belong to the taxane family. Buyers typically request these materials in high‑purity forms (≥98 % by HPLC) for pre‑clinical studies or as intermediates for further synthesis. Because the supplier’s catalogue does not mention specific grades or certifications, purchasers must verify compliance with relevant pharmacopeial standards such as USP, EP, or JP before procurement.

The catalogue focuses on five anticancer agents: Vinorelbine tartrate, Vinorelbine base, Vinblastine sulfate, Docetaxel, and Paclitaxel. These are classified chemically as alkaloid salts (vinblastine series) and taxane esters (docetaxel, paclitaxel). In the broader industry, such raw materials are supplied in grades ranging from research‑grade (≥95 % purity) to GMP‑grade (≥99 % purity) and are often accompanied by a Certificate of Analysis (CoA) confirming assay, impurity profile, and residual solvent limits. Typical specifications include water content below 0.5 % (Karl Fischer), heavy metal limits per USP <232>, and endotoxin levels under 0.5 EU/mL for injectable intermediates.

Industrial‑chemical and laboratory‑chemical categories associated with these compounds usually require compliance with ISO 9001 quality‑management systems and, for pharmaceutical intermediates, Good Manufacturing Practice (GMP) certification. Buyers also look for stability data covering temperature ranges (e.g., - 20 °C to 25 °C) and light‑sensitivity testing, especially for taxanes that degrade under UV exposure. Packaging options in the industry include amber glass vials, sealed HDPE drums, or nitrogen‑purged bulk bags, each selected to maintain moisture and oxygen barriers.